Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial von GILBERT, Mark R, MEIHUA WANG, MAHAJAN, Anita, SCHULTZ, Christopher J, ERRIDGE, Sara, BAUMERT, Brigitta, HOPKINS, Kristen I, TZUK-SHINA, Tzahala, BROWN, Paul D, CHAKRAVARTI, Arnab, CURRAN, Walter J, MEHTA, Minesh P, ALDAPE, Kenneth D, STUPP, Roger, HEGI, Monika E, JAECKLE, Kurt A, ARMSTRONG, Terri S, WEFEL, Jeffrey S, MINHEE WON, BLUMENTHAL, Deborah T

Volltext

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma von Gilbert, Mark R, Dignam, James J, Armstrong, Terri S, Wefel, Jeffrey S, Blumenthal, Deborah T, Vogelbaum, Michael A, Colman, Howard, Chakravarti, Arnab, Pugh, Stephanie, Won, Minhee, Jeraj, Robert, Brown, Paul D, Jaeckle, Kurt A, Schiff, David, Stieber, Volker W, Brachman, David G, Werner-Wasik, Maria, Tremont-Lukats, Ivo W, Sulman, Erik P, Aldape, Kenneth D, Curran, Walter J, Mehta, Minesh P

Volltext

Liquid biopsy in gliomas: A RANO review and proposals for clinical applications von Soffietti, Riccardo, Bettegowda, Chetan, Mellinghoff, Ingo K, Warren, Katherine E, Ahluwalia, Manmeet S, De Groot, John F, Galanis, Evanthia, Gilbert, Mark R, Jaeckle, Kurt A, Le Rhun, Emilie, Rudà, Roberta, Seoane, Joan, Thon, Niklas, Umemura, Yoshie, Weller, Michael, van den Bent, Martin J, Vogelbaum, Michael A, Chang, Susan M, Wen, Patrick Y

Volltext

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study von GALANIS, Evanthia, JAECKLE, Kurt A, RICHON, Victoria M, SCHEITHAUER, Bernd, GIANNINI, Caterina, FLYNN, Patrick J, MOORE, Dennis F, ZWIEBEL, James, BUCKNER, Jan C, MAURER, Matthew J, REID, Joel M, AMES, Matthew M, HARDWICK, James S, REILLY, John F, LOBODA, Andrey, NEBOZHYN, Michael, FANTIN, Valeria R

Volltext

Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study von Galanis, Evanthia, Buckner, Jan C, Maurer, Matthew J, Kreisberg, Jeffrey I, Ballman, Karla, Boni, J, Peralba, Josep M, Jenkins, Robert B, Dakhil, Shaker R, Morton, Roscoe F, Jaeckle, Kurt A, Scheithauer, Bernd W, Dancey, Janet, Hidalgo, Manuel, Walsh, Daniel J

Volltext

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177 von Brown, Paul D, Krishnan, Sunil, Sarkaria, Jann N, Wu, Wenting, Jaeckle, Kurt A, Uhm, Joon H, Geoffroy, Francois J, Arusell, Robert, Kitange, Gaspar, Jenkins, Robert B, Kugler, John W, Morton, Roscoe F, Rowland, Jr, Kendrith M, Mischel, Paul, Yong, William H, Scheithauer, Bernd W, Schiff, David, Giannini, Caterina, Buckner, Jan C

Volltext

Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074 von Uhm, Joon H., M.D, Ballman, Karla V., Ph.D, Wu, Wenting, Ph.D, Giannini, Caterina, M.D, Krauss, J.C., M.D, Buckner, Jan C., M.D, James, C.D., Ph.D, Scheithauer, Bernd W., M.D, Behrens, Robert J., M.D, Flynn, Patrick J., M.D, Schaefer, Paul L., M.D, Dakhill, Shaker R., M.D, Jaeckle, Kurt A., M.D

Volltext

Is There an Association Between Meningioma and Hormone Replacement Therapy? von BLITSHTEYN, Svetlana, CROOK, Julia E, JAECKLE, Kurt A

Volltext

Pathway analysis of primary central nervous system lymphoma von Tun, Han W., Personett, David, Baskerville, Karen A., Menke, David M., Jaeckle, Kurt A., Kreinest, Pamela, Edenfield, Brandy, Zubair, Abba C., O'Neill, Brian P., Lai, Weil R., Park, Peter J., McKinney, Michael

Volltext

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma... von Sarkaria, Jann N., M.D, Galanis, Evanthia, M.D, Wu, Wenting, Ph.D, Peller, Patrick J., M.D, Giannini, Caterina, M.D, Brown, Paul D., M.D, Uhm, Joon H., M.D, McGraw, Steven, M.D, Jaeckle, Kurt A., M.D, Buckner, Jan C., M.D

Volltext

Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases von Jaeckle, Kurt A., Dixon, Jesse G., Anderson, Stephen Keith, Moreno‐Aspitia, Alvaro, Colon‐Otero, Gerardo, Hebenstreit, Kathy, Patel, Tejal A., Reddy, Samarth L., Perez, Edith A.

Volltext

Clinical features and outcomes in primary nervous system histiocytic neoplasms von Nathoo, Nabeela, Uhm, Joon H., Porter, Alyx B., Hammack, Julie, Jaeckle, Kurt A., Mrugala, Maciej M., Crum, Brian A., Flanagan, Eoin P., Pittock, Sean J., Goyal, Gaurav, Young, Jason R., Koster, Matthew J., Vassallo, Robert, Ryu, Jay H., Davidge-Pitts, Caroline J., Bach, Corrie, Ravindran, Aishwarya, Sartori Valinotti, Julio C., Bennani, N. Nora, Abeykoon, Jithma P., Shah, Mithun V., Hook, C. Christopher, Rech, Karen L., Go, Ronald S., Tobin, W. Oliver

Volltext

Detrimental Effects of Tumor Progression on Cognitive Function of Patients With High-Grade Glioma von BROWN, Paul D, JENSEN, Ashley W, FELTEN, Sara J, BALLMAN, Karla V, SCHAEFER, Paul L, JAECKLE, Kurt A, CERHAN, Jane H, BUCKNER, Jan C

Volltext

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma von Tun, Han W., Johnston, Patrick B., DeAngelis, Lisa M., Atherton, Pamela J., Pederson, Levi D., Koenig, Patricia A., Reeder, Craig B., Omuro, Antonio M. Padula, Schiff, David, O'Neill, Brian, Pulido, Jose, Jaeckle, Kurt A., Grommes, Christian, Witzig, Thomas E.

Volltext

Oligodendroglial Tumors von Jaeckle, Kurt A

Volltext

Phase II Evaluation of Temozolomide and 13-cis-Retinoic Acid for the Treatment of Recurrent and Progressive Malignant Glioma: A North American Brain Tumor Consortium Study von JAECKLE, Kurt A, HESS, Kenneth R, CLOUGHESY, Timothy, NICHOLAS, M. Kelly, CHANG, Susan, PRADOS, Michael, YUNG, W. K, GREENBERG, Harry, FINE, Howard, SCHIFF, David, POLLACK, Ian F, KUHN, John, FINK, Karen, MEHTA, Minesh

Volltext

Neurological Manifestations of Neoplastic and Radiation-Induced Plexopathies von Jaeckle, Kurt A

Volltext

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design von Jaeckle, Kurt A, Ballman, Karla V, van den Bent, Martin, Giannini, Caterina, Galanis, Evanthia, Brown, Paul D, Jenkins, Robert B, Cairncross, J Gregory, Wick, Wolfgang, Weller, Michael, Aldape, Kenneth D, Dixon, Jesse G, Anderson, S Keith, Cerhan, Jane H, Wefel, Jeffrey S, Klein, Martin, Grossman, Stuart A, Schiff, David, Raizer, Jeffrey J, Dhermain, Frederick, Nordstrom, Donald G, Flynn, Patrick J, Vogelbaum, Michael A

Volltext

Current Strategies in Treatment of Oligodendroglioma: Evolution of Molecular Signatures of Response von Jaeckle, Kurt A, Ballman, Karla V, Rao, Ravi D, Jenkins, Robert B, Buckner, Jan C

Volltext

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial von GALANIS, Evanthia, KEITH ANDERSON, S, KAUFMANN, Timothy J, BUCKNER, Jan C, LAFKY, Jackie M, UHM, Joon H, GIANNINI, Caterina, KUMAR, Shaji K, KIMLINGER, Teresa K, NORTHFELT, Donald W, FLYNN, Patrick J, JAECKLE, Kurt A

Volltext